Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission?
- PMID: 19864585
- PMCID: PMC6665007
- DOI: 10.1523/JNEUROSCI.4172-09.2009
Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission?
Abstract
Effects of antipsychotic drugs have widely been considered to be mediated by blockade of postsynaptic dopamine D(2) receptors. Effects of antipsychotics on presynaptic functions of dopaminergic neurotransmission might also be related to therapeutic effects of antipsychotics. To investigate the effects of antipsychotics on presynaptic functions of dopaminergic neurotransmission in relation with occupancy of dopamine D(2) receptors, changes in dopamine synthesis capacity by antipsychotics and occupancy of dopamine D(2) receptors were measured by positron emission tomography (PET) in healthy men. PET studies using [(11)C]raclopride and L-[beta-(11)C]DOPA were performed under resting condition and oral administration of single dose of the antipsychotic drug risperidone on separate days. Although occupancy of dopamine D(2) receptors corresponding dose of risperidone was observed, the changes in dopamine synthesis capacity by the administration of risperidone were not significant, nor was the relation between the occupancy of dopamine D(2) receptors and these changes. A significant negative correlation was observed between the baseline dopamine synthesis capacity and the changes in dopamine synthesis capacity by risperidone, indicating that this antipsychotic can be assumed to stabilize the dopamine synthesis capacity. The therapeutic effects of risperidone in schizophrenia might be related to such stabilizing effects on dopaminergic neurotransmission responsivity.
Figures



Similar articles
-
Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.PLoS One. 2012;7(9):e46488. doi: 10.1371/journal.pone.0046488. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23029533 Free PMC article.
-
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.Am J Psychiatry. 2006 Mar;163(3):396-401. doi: 10.1176/appi.ajp.163.3.396. Am J Psychiatry. 2006. PMID: 16513859
-
The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.Arch Gen Psychiatry. 2009 Jun;66(6):606-15. doi: 10.1001/archgenpsychiatry.2009.43. Arch Gen Psychiatry. 2009. PMID: 19487625 Clinical Trial.
-
Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.J Clin Psychopharmacol. 2013 Oct;33(5):675-81. doi: 10.1097/JCP.0b013e3182983ffa. J Clin Psychopharmacol. 2013. PMID: 23948784 Review.
-
Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable.Eur Neuropsychopharmacol. 2006 May;16(4):233-40. doi: 10.1016/j.euroneuro.2005.10.006. Epub 2005 Dec 2. Eur Neuropsychopharmacol. 2006. PMID: 16326078 Review.
Cited by
-
Effect of the TAAR1 Partial Agonist Ralmitaront on Presynaptic Dopamine Synthesis Capacity Measured Using [18F]DOPA PET in Naïve and Cocaine-Treated Mice.Mol Imaging. 2024 Dec 18;23:15353508241299546. doi: 10.1177/15353508241299546. eCollection 2024 Jan-Dec. Mol Imaging. 2024. PMID: 40098750 Free PMC article.
-
New Modified UPLC/Tandem Mass Spectrometry Method for Determination of Risperidone and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Dose-Dependent Pharmacokinetic Study in Sprague-Dawley Rats.Int J Anal Chem. 2017;2017:1271383. doi: 10.1155/2017/1271383. Epub 2017 May 3. Int J Anal Chem. 2017. PMID: 28553353 Free PMC article.
-
Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.PLoS One. 2012;7(9):e46488. doi: 10.1371/journal.pone.0046488. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23029533 Free PMC article.
-
Epigenetics and biomarkers in the staging of neuropsychiatric disorders.Neurotox Res. 2010 Nov;18(3-4):347-66. doi: 10.1007/s12640-010-9163-5. Epub 2010 Mar 17. Neurotox Res. 2010. PMID: 20237880 Review.
-
Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior.Eur J Histochem. 2021 Oct 13;65(s1):3284. doi: 10.4081/ejh.2021.3284. Eur J Histochem. 2021. PMID: 34643358 Free PMC article. Review.
References
-
- Balsara JJ, Jadhav JH, Chandorkar AG. Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology (Berl) 1979;62:67–69. - PubMed
-
- Baron JC, Martinot JL, Cambon H, Boulenger JP, Poirier MF, Caillard V, Blin J, Huret JD, Loc'h C, Maziere B. Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology (Berl) 1989;99:463–472. - PubMed
-
- Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med. 1997;38:1614–1623. - PubMed
-
- Brown RM, Crane AM, Goldman PS. Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates. Brain Res. 1979;168:133–150. - PubMed
-
- Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 1963;20:140–144. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources